NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Hero MotoCorp Reports Strong Q4FY26 and FY26 Performance

Hero MotoCorp (HMCL) has reported a strong performance in its Q4FY26 and FY26 results, driven by broad-based growth, improved margin, healthy demand traction, and disciplined execution across its core segments. The company's tailwinds from the marriage season and upcoming pay commission development are expected to support entry-level demand. Additionally, new launches in the 125cc segment and steady ASP growth of approximately 3% quarter-on-quarter in Q4FY26 have aided mix improvement.

The company's dealer inventory has corrected to approximately 5 weeks in Q4FY26, indicating a healthy retail traction. Management expects a gradual recovery in rural demand, which will further support volumes going forward. This optimistic outlook is likely to drive the company's growth in the coming quarters.

FY27/28E EPS Estimate and Target Price

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In response to the company's strong performance, we have marginally revised our FY27/28E EPS estimate. Our target price for Hero MotoCorp remains at INR 6,000. We value the company at 18x (maintained) P/E multiple, which corresponds to an implied PEG of 1.7x on FY28E EPS.

Hero MotoCorp
FY27/28E EPS EstimateMarginally revised
Target PriceINR 6,000
P/E Multiple18x (maintained)
Implied PEG1.7x on FY28E EPS

Investor Takeaway

Analysts recommend buying Hero MotoCorp with a target price of Rs 6000.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.